EP Patent

EP0302481A2 — Use of free fatty acids for the manufacture of a medicament for treatment of diabetes mellitus

Assigned to Century Laboratories Inc · Expires 1989-02-08 · 37y expired

What this patent protects

Eicosapentaenoic acid and docosahexaenoic acid, in free acid form or in the form of a pharmaceutically acceptable salt thereof, are useful in treating diabetes mellitus. The free fatty acids (or salts) were an order of magnitude more effective in treating arthritis than the same …

USPTO Abstract

Eicosapentaenoic acid and docosahexaenoic acid, in free acid form or in the form of a pharmaceutically acceptable salt thereof, are useful in treating diabetes mellitus. The free fatty acids (or salts) were an order of magnitude more effective in treating arthritis than the same amount of EPA and DHA in their triglyceride form.

Drugs covered by this patent

Patent Metadata

Patent number
EP0302481A2
Jurisdiction
EP
Classification
—
Expires
1989-02-08
Drug substance claim
No
Drug product claim
No
Assignee
Century Laboratories Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.